This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitair Medisch Centrum Utrecht. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Anne Christensen: Innovator in cAMP Modulation
Introduction
Anne Christensen is a notable inventor based in Bergen, Norway. She has made significant contributions to the field of biochemistry, particularly in the modulation of exchange proteins directly activated by cAMP (Epacs). Her work has implications for the treatment of various diseases, showcasing her commitment to advancing medical science.
Latest Patents
Anne Christensen holds 1 patent for her invention titled "Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs)." This invention relates to novel compounds that specifically modulate the activity of Epacs, which are crucial in various biological processes. The patent details the development of cAMP analogues that can influence the activity of these proteins. Notably, the compounds include substituted deoxyadenosine-cyclic monosphosphates. Furthermore, the invention encompasses pharmaceutical compositions that utilize these novel compounds for treating diseases such as cancer, chronic inflammation, thrombosis, and type-2 diabetes mellitus in both humans and animals.
Career Highlights
Anne Christensen is affiliated with the Universitair Medisch Centrum Utrecht, where she continues her research and development efforts. Her work is characterized by a strong focus on innovative solutions to complex medical challenges.
Collaborations
One of her notable collaborators is John De Koning, with whom she has worked on various projects related to her research.
Conclusion
Anne Christensen's contributions to the field of biochemistry, particularly through her patent on cAMP modulation, highlight her role as an innovator in medical science. Her work has the potential to impact the treatment of significant health issues, demonstrating the importance of her research in advancing therapeutic options.